Company
NuBloom
NuBloom publishes compounded semaglutide and compounded tirzepatide, from $149 to $279 a month.
- 2 programs
- 2 molecules
- 2 readings
Read from mynubloom.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to NuBloom
We earn nothing from this link. NuBloom has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · Starting price
first month, including the required fees on record · Starting price
Terms
| States | All states except Mississippi |
|---|
Not yet checked: pharmacy, membership and consultation fee.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. This is a genuine served-state LIST (a dedicated 'States Served' page), not an exclusion list, and it is worth flagging that it names 49 of the 50 states in standard alphabetical order — Mississippi is the one state conspicuously missing from an otherwise complete A-Z run. Recorded exactly as printed (49 states, no editorializing to '50' and no silent addition of the missing one). NuBloom explicitly states it deliberately does NOT prescribe GLP-1 in pill form as a clinical choice ('At NuBloom, GLP-1 treatment is offered as an injection rather than a pill... that is why we only offer GLP-1 injections'), so form is very likely a vial or pen, but the word 'vial' is never used, so per the brief's caution against inferring, form is left not-disclosed. Also offers a non-GLP-1 bupropion/naltrexone combo ($139/mo) and a 90-Day Guided Support Program pairing GLP-1 with coaching, neither entered as separate GLP-1 rows.
Before you act
Cite this
Treatment Registry. (2026). NuBloom: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/nubloom